Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)

SHA:600867 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	688.08	586.6	1,104	788.06	865.04	593.38
Trading Asset Securities	55	55.4	55.52	58.46	37	150.37
Cash & Short-Term Investments	743.08	642	1,160	846.52	902.04	743.74
Cash Growth	-36.67%	-44.64%	37.00%	-6.15%	21.28%	30.31%
Accounts Receivable	496.51	547.57	869.74	455.99	650.94	571.27
Other Receivables	9.7	7.88	8.79	20.56	7.63	18.05
Receivables	506.2	555.45	878.53	476.55	658.57	589.32
Inventory	754	736.31	705.35	653.9	537.92	537.58
Prepaid Expenses	-	-	-	0.02	0.03	0.57
Other Current Assets	93.93	72.56	72.76	79.43	63.9	51.2
Total Current Assets	2,097	2,006	2,816	2,056	2,162	1,922
Property, Plant & Equipment	2,695	2,732	2,671	2,678	2,392	2,288
Long-Term Investments	686.59	627.75	435.01	362.49	457.91	461.79
Other Intangible Assets	628.47	628.05	670.02	487.01	389.07	256.32
Long-Term Deferred Tax Assets	135.3	142.91	38.55	46.19	42.41	37.75
Long-Term Deferred Charges	1,013	977.32	690.91	607.25	447.29	357.83
Other Long-Term Assets	293.03	264.08	449.84	513.13	628.85	479.58
Total Assets	7,548	7,379	7,771	6,750	6,520	5,803
Accounts Payable	117.34	96.62	115.9	80.86	75	68.17
Accrued Expenses	4.85	51.07	30.93	11.03	31.74	15.99
Short-Term Debt	537.25	416.76	150	-	-	-
Current Portion of Leases	-	4.4	-	-	-	-
Current Income Taxes Payable	26.76	-	52.46	-	80.45	37.48
Current Unearned Revenue	5.94	16.07	10.48	21.08	7.89	8.17
Other Current Liabilities	33.14	80.52	160.39	49.08	73.47	78.37
Total Current Liabilities	725.29	665.44	520.16	162.05	268.55	208.18
Long-Term Debt	253.49	253.49	-	2.65	2.65	2.65
Long-Term Leases	18.61	19.5	-	-	-	-
Long-Term Unearned Revenue	27.36	27.66	27.51	28.53	28.67	32.91
Long-Term Deferred Tax Liabilities	11.86	11.99	7.41	7.51	-	0.06
Total Liabilities	1,037	978.08	555.08	200.74	299.87	243.8
Common Stock	1,959	1,982	1,994	1,994	2,034	2,034
Additional Paid-In Capital	354.13	508.77	622.56	641.9	1,006	1,034
Retained Earnings	4,296	4,186	4,725	4,053	3,567	2,679
Treasury Stock	-120.24	-300.28	-134.83	-150.37	-398.13	-200.49
Comprehensive Income & Other	6.91	6.91	5.28	6.39	6.94	7.48
Total Common Equity	6,495	6,384	7,211	6,544	6,215	5,554
Minority Interest	16.86	16.89	5.09	5.31	5.35	5.47
Shareholders' Equity	6,512	6,400	7,216	6,550	6,220	5,559
Total Liabilities & Equity	7,548	7,379	7,771	6,750	6,520	5,803
Total Debt	809.35	694.15	150	2.65	2.65	2.65
Net Cash (Debt)	-66.26	-52.15	1,010	843.87	899.39	741.09
Net Cash Growth	-	-	19.65%	-6.17%	21.36%	67.25%
Net Cash Per Share	-0.03	-0.02	0.51	0.42	0.44	0.37
Filing Date Shares Outstanding	1,943	1,907	1,916	1,984	2,018	2,018
Total Common Shares Outstanding	1,943	1,907	1,916	1,984	2,018	2,018
Working Capital	1,372	1,341	2,296	1,894	1,894	1,714
Book Value Per Share	3.34	3.35	3.76	3.30	3.08	2.75
Tangible Book Value	5,866	5,755	6,541	6,057	5,826	5,298
Tangible Book Value Per Share	3.02	3.02	3.41	3.05	2.89	2.63
Buildings	-	1,829	1,437	1,452	1,305	1,198
Machinery	-	2,356	1,532	1,591	1,301	1,431
Construction In Progress	-	226.11	1,319	1,158	1,203	1,210

Source: S&P Global Market Intelligence. Standard template. Financial Sources.